Skip to main content
OpenTrials
Completed

NCT Number: NCT04642001

Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions

This randomized, double-blind clinical trial evaluated the effect of photobimodulation associated with 8% strontium acetate in the treatment of dentin hypersensitivity in non-carious lesions and analyzed the risk factors with the patient's quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dental Hypersensitivity

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universidade Federal do Pará

Belém, Pará, 66075-110, Brazil

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 to 50 years
  • Good general health
  • Dental sensitivity with response ≥ 4 on the 10 cm long visual analog scale (EVA)
  • Presence of at least two hypersensitive teeth with a depth of up to 1 mm (measured with a millimeter probe)
  • Exposed root surface caused by abrasion, erosion or gum recession

Exclusion criteria

  • Volunteers using analgesic medication
  • Presence of teeth with evidence of carious lesions, pulpitis, defective restorations and moderate or severe periodontal disease
  • Patients who had undergone any whitening therapy or professional or homemade desensitizer in the last six months
  • Patient with fixed orthodontic appliances
  • Drug users or pregnant women were also excluded.

Treatment and study plan

Photon Laser III-DMC (without radiation emission) + My First- Colgate

Other

Positioning of the FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day.

Photon Laser III-DMC (without radiation emission) + Sensodyne® Rapid Relief / GSK

Other

Positioning of FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day.

Photon Laser III-DMC (with irradiation emission) + My First- Colgate

Radiation

Emission of FBM therapy (Photon Laser III / DMC), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day.

Photon Laser III-DMC (with irradiation emission) +Sensodyne® Rapid Relief / GSK

Combination Product

Emission of FBM therapy (Photon Laser III / DMC), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day.

Primary outcomes

  1. dentin sensitivity

    Time frame: 30 days after the end of treatment

    evaluation of dentinal sensitivity during treatment and one month after its end, by means of tactile and evaporative stimuli according to the visual analog scale with values from 0 to 10, with higher values indicating a worse level of pain.

Sponsors and collaborators

Lead sponsor

Universidade Federal do Para

Other

Registry information

Official study title

Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions: A Randomized, Double-blind Clinical Trial.

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Nov 24, 2020
Registry last updated
Nov 27, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.